PrEP, PEP & nPEP

PrEP (Pre-Exposure Prophylaxis)  A comprehensive HIV prevention strategy that involves the daily use of antiretroviral medications to reduce the risk of HIV infection in HIV-negative individuals.

PEP (Post-Exposure Prophylaxis) Taking antiretroviral medicines (ART) after being potentially exposed to HIV to prevent becoming infected.

nPEP (Non-occupational Post-Exposure Prophylaxis) Short-term treatment started as soon as possible after high-risk non-occupational exposure to an infectious agent, such as HIV, hepatitis B virus (HBV), or hepatitis C virus (HCV).

COVID-19 PrEP Access Updates

• HHS Implements Override Request 
• Ready, Set, PrEP Expands 
• Prior Authorization, Regional Disparities
• PrEP During COVID-19 (HIV.gov) The Centers for Disease Control and Prevention (CDC) understands that its partners in HIV prevention are facing unprecedented challenges and demands as we continue to battle the COVID-19 pandemic together. CDC has developed guidance for providing PrEP when facility-based services and in-person patient-clinician contact is limited.

News

• HealthHIV becomes the new home for PleasePrEPMe.org, the original comprehensive PrEP online resource  As of Friday, January 15, 2021, HealthHIV will be the new home of PleasePrEPMe.org, an online platform that expands access to pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). Initially launched in 2015 as a searchable and location-responsive provider directory for the State of California, PleasePrEPMe.org has expanded to provide HIV prevention resources in English and Spanish for consumers and providers in all 50 states. The platform features an online PrEP navigation training program with multiple modules/courses and downloadable resources which offer comprehensive insights and highlight best practices for PrEP consumers, navigators, and prescribers.
• HHS Seeks Vendor(s) to Distribute PrEP Medications as Part of Ready, Set, PrEP * (HIV.gov) The U.S. Department of Health & Human Services (HHS) requires a vendor(s) to distribute pre-exposure prophylaxis (PrEP) medications as part of a donation agreement between HHS and Gilead to provide PrEP medication at no cost for up to 200,000 individuals a year who are at risk for HIV and who are uninsured.
• Ready, Set, PrEP Expands Access to Medication to Prevent HIV *  HRSA News December 3 – The U.S. Department of Health and Human Services (HHS) today launched Ready, Set, PrEP, a national program that makes medications for pre-exposure prophylaxis (PrEP), taken daily to prevent HIV, available at no cost to people without prescription drug insurance coverage.

Resources

• FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic *
• AIDSinfo HIV Prevention Consumer Fact Sheets: Post-Exposure Prophylaxis (PEP) *
• AIDSinfo HIV Prevention Consumer Fact Sheets: Pre-Exposure Prophylaxis (PrEP) *
• AIDSVu Adds 2017 State-Level Data Visualizing PrEP Users Across the U.S. *
• Sexual Assault: PEP is an Urgent Health Need *
• PrEPcost.org is Now Available for 2019 Individual Health Plans *
• NASTAD’s PrEPcost.org Training Video *
• New CDC Initiative Educates Providers about PrEP and PEP *
• CDC Discussions on Pre-Exposure Prophylaxis and Women: Summary *
• The Miami-Dade County PrEP/PEP Provider brochure
• PrEP Locator – www.preplocator.org *
• Medication Assistance Program and Co-Pay Programs for PrEP *
• HIV/STD and PrEP Website from the Free UHealth Clinic at Walgreens *
• PrEP Study at University of Miami Miller School of Medicine (Ft. Lauderdale)